Literature DB >> 15218078

Identification of liver receptor homolog-1 as a novel regulator of apolipoprotein AI gene transcription.

Philippe Delerive1, Cristin M Galardi, John E Bisi, Edwige Nicodeme, Bryan Goodwin.   

Abstract

The orphan nuclear receptor liver receptor homolog-1 (LRH-1) has been reported to play a role in bile acid biosynthesis and reverse cholesterol transport. In this study, we examined the role of LRH-1 in the regulation of the apolipoprotein AI (APOAI) gene. Using RNA interference and adenovirus-mediated overexpression, we show that LRH-1 directly regulates APOAI gene transcription. Transient transfection experiments and EMSAs revealed that LRH-1 directly regulates APOAI transcription by binding to an LRH-1 response element located in the proximal APOAI promoter region. Chromatin immunoprecipitation experiments revealed that LRH-1 binds to the human APO AI promoter in vivo. Finally, we show that the transcriptional repressor SHP (small heterodimer partner) suppressed APOAI gene expression by inhibiting LRH-1 transcriptional activity. Taken together, our results demonstrate that LRH-1 is a novel regulator of APOAI transcription and underscore the role of this receptor in cholesterol homeostasis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15218078     DOI: 10.1210/me.2004-0132

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  23 in total

Review 1.  Emerging actions of the nuclear receptor LRH-1 in the gut.

Authors:  Pablo J Fernandez-Marcos; Johan Auwerx; Kristina Schoonjans
Journal:  Biochim Biophys Acta       Date:  2010-12-29

2.  LRH-1-dependent glucose sensing determines intermediary metabolism in liver.

Authors:  Maaike H Oosterveer; Chikage Mataki; Hiroyasu Yamamoto; Taoufiq Harach; Norman Moullan; Theo H van Dijk; Eduard Ayuso; Fatima Bosch; Catherine Postic; Albert K Groen; Johan Auwerx; Kristina Schoonjans
Journal:  J Clin Invest       Date:  2012-07-09       Impact factor: 14.808

3.  Liver receptor homolog 1 is a negative regulator of the hepatic acute-phase response.

Authors:  Nicolas Venteclef; Jason C Smith; Bryan Goodwin; Philippe Delerive
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

Review 4.  Molecular regulation of HDL metabolism and function: implications for novel therapies.

Authors:  Daniel J Rader
Journal:  J Clin Invest       Date:  2006-12       Impact factor: 14.808

Review 5.  Role of nuclear receptor SHP in metabolism and cancer.

Authors:  Yuxia Zhang; Curt H Hagedorn; Li Wang
Journal:  Biochim Biophys Acta       Date:  2010-10-20

Review 6.  Cell signaling and nuclear receptors: new opportunities for molecular pharmaceuticals in liver disease.

Authors:  Jeff L Staudinger; Kristin Lichti
Journal:  Mol Pharm       Date:  2007-12-27       Impact factor: 4.939

7.  alpha(1)-fetoprotein transcription factor (FTF)/liver receptor homolog-1 (LRH-1) is an essential lipogenic regulator.

Authors:  Zhumei Xu; Lingli Ouyang; Antonio Del Castillo-Olivares; William M Pandak; Gregorio Gil
Journal:  Biochim Biophys Acta       Date:  2009-12-28

Review 8.  Therapeutic interventions to enhance apolipoprotein A-I-mediated cardioprotection.

Authors:  Michael J Haas; Arshag D Mooradian
Journal:  Drugs       Date:  2010-05-07       Impact factor: 9.546

9.  Ligand-dependent regulation of the activity of the orphan nuclear receptor, small heterodimer partner (SHP), in the repression of bile acid biosynthetic CYP7A1 and CYP8B1 genes.

Authors:  Ji Miao; Sung-E Choi; Sun Mi Seok; Linda Yang; William J Zuercher; Yong Xu; Timothy M Willson; H Eric Xu; Jongsook Kim Kemper
Journal:  Mol Endocrinol       Date:  2011-05-12

10.  Liver receptor homolog 1 transcriptionally regulates human bile salt export pump expression.

Authors:  Xiulong Song; Rajani Kaimal; Bingfang Yan; Ruitang Deng
Journal:  J Lipid Res       Date:  2008-02-12       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.